TP53 and hepatocellular carcinoma: Zhang et al. (2020b) found BRD7 upregulation, mitochondrial translocation of p53, a combination of SLC25A28 and p53, and ferroptosis induction in HSCs in patients with advanced hepatocellular carcinoma fibrosis treated with sorafenib.